Opsonix, Inc. Company Profile, Contacts & Intelligence

Opsonix, Inc. Overview

Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis. Opsonix’s pathogen-capture proteins are engineered versions of human opsonins—molecular components of the innate immune system that help to clear our bodies of pathogens and released toxins. Our most advanced pathogen-capture protein, FcMBL, binds all types of microorganisms, including bacteria, fungi, parasites and viruses, as well as many toxins. The pathogen-extracting therapy incorporates FcMBL into an extracorporeal medical device to remove infectious agents from circulating blood in patients with systemic infections that are the cause of sepsis.

Headquarters

Cambridge, Ma

Website

opsonixbio.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Opsonix, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Compare Similar Companies to Opsonix, Inc.

Explore companies in related markets and compare their industry and employee estimates.